Τίτλος:
Assessment of HIV testing recommendations in Greek specialty guidelines: A missed opportunity and room for improvement for recommending testing
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
HIV testing for individuals presenting with indicator conditions (ICs) including AIDS-defining conditions (ADCs) is explicitly recommended by European guidelines. We aimed to review specialty guidelines in Greece and assess if HIV was discussed and testing recommended. We reviewed European guidelines to produce a list of 25 ADCs and 48 ICs. We identified Greek guidelines for 11 of 25 (44%) ADCs and 30 of 48 (63%) ICs. In total, 47 guidelines were reviewed (range: 1–6 per condition); 11 (23%) for ADCs and 36 (77%) for ICs. Association with HIV was discussed in 7 of 11 (64%) ADC and 8 of 36 IC guidelines (22%), whereas HIV testing was appropriately recommended in two of 11 ADC (18%) and 10 of 36 IC guidelines (28%). Significant differences were found for the distribution of recommendations to test in both types of condition, with ICs having higher percentage of non-recommendation (50%, p < 0.05). No association was found between source of guideline or publication year and testing recommendation. Most guidelines for ICs and ADCs do not recommend testing. Specialists managing most ICs and ADCs may be unaware of the actual prevalence of undiagnosed HIV infection among their patients or the respective recommendations produced by HIV societies. © 2021 Informa UK Limited, trading as Taylor & Francis Group.
Συγγραφείς:
Akinosoglou, K.
Kostaki, E.G.
Paraskevis, D.
Gogos, C.A.
Περιοδικό:
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
Λέξεις-κλειδιά:
adult; Article; clinical article; controlled study; female; Greece; human; Human immunodeficiency virus; Human immunodeficiency virus infection; male; organization; practice guideline; prevalence; public health service; acquired immune deficiency syndrome; Greece; HIV test; Human immunodeficiency virus infection, Acquired Immunodeficiency Syndrome; Greece; HIV Infections; HIV Testing; Humans; Prevalence
DOI:
10.1080/09540121.2021.1876837
